Re: RBC unregistered to registered account
in response to
by
posted on
Mar 29, 2019 07:46AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
narmac....DM simply needs to IPO Zenith for the reason you stated and for RVX stockholders that do not own Zenith shares but remained loyal to Resverlogix through thick and thin post SPINCO...eh!.
Surprising that Shenzhen Hepalink has not invested in Zenith...or have they?
IMO...Koo